Yuhua Ru^1*, Jinjin Zhu^2*, Huanle Gong, PhD^3*, Mimi Xu, MD^1*, Ying Wang^4*, Miao Miao, MD^5*, Suning Chen, MD, PhD^6*, Xiang Zhang^7*, Yi Fan^8*, Yang Xu^3*, Jia Chen^5* and Depei Wu, MD, PhD⁹

¹The First Affiliated Hospital of Soochow University, Suzhou, CHN
²The first affiliated hospital of Soochow University, Suzhou, China
³The First Affiliated Hospital Of Soochow University, Suzhou, China
⁴The First Affiliated Hospital of Soochow University, Suzhou, China
⁵National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China
⁶The first Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center of Hematologic Diseases, Suzhou, China
⁷Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
⁸The First Affilliated Hospital of Soochow University, Suzhou, CHN
⁹Department of Hematology, the First Affiliated Hospital of Soochow University, Collaborative Innovation Center of Hematology, Institute of Blood and Marrow Transplantation, Suzhou, China

Lev Gorfinkel, MD^1,2,3, Muna Qayed, MD⁴, Brandi Bratrude^5*, Kayla Betz, BS^6*, Kyle Hebert, MS^7*, Sung W. Choi, MD, MS⁸, Jeffrey Davis^9*, Christine Duncan^10,11,12, Roger H. Giller, MD^13*, Michael S. Grimley, MD¹⁴, Andrew Harris, MD^15*, David A Jacobsohn, MD¹⁶, Nahal Lalefar, MD^17*, Nosha Farhadfar, MD^18*, Michael A. Pulsipher, MD¹⁹, Shalini Shenoy, MD²⁰, Aleksandra Petrovic, MD^21*, Kirk R. Schultz, MD²², Gregory Yanik, MD^23*, Bruce R Blazar, MD²⁴, John T. Horan, MD²⁵, Amelia Langston, MD²⁶, Leslie Kean, MD²⁷ and Benjamin Watkins, MD²⁸

¹Division of Hematology-Oncology, Boston Children's Hospital, Boston, MA
²Harvard Medical School, Boston, MA
³Dana-Farber Cancer Institute, Boston, MA
⁴Division of Pediatric Hematology, Oncology and Bone Marrow Transplantation, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA
⁵Boston Children's Hospital, Boston
⁶Boston Children's Hospital, boston, MA
⁷Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
⁸Blood and Marrow Transplantation Program, University of Michigan, Ann Arbor, MI
⁹BC Children's Hospital, Oak Harbor, WA
¹⁰Division of Pediatric Hematology/Oncology, Boston Children’s Hospital, Boston, MA
¹¹Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA
¹²Department of Pediatrics, Harvard Medical School, Boston, MA
¹³University of Colorado SOM / Childrens Hospital Colorado, Denver, CO
¹⁴Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
¹⁵Pediatric Stem Cell Transplantation and Cellular Therapies Service, Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY
¹⁶Children's National Medical Center, Washington, DC
¹⁷UCSF Benioff Children's Hospital Oakland, Oakland, CA
¹⁸University of Florida, Gainesville, FL
¹⁹Huntsman Cancer Institute, Salt Lake City, UT
²⁰Department of Pediatrics, Division of Hematology / Oncology, Washington University Medical Center, Saint Louis, MO
²¹Fred Hutchinson Cancer Center, Seattle, WA
²²B.C. Children's Hospital, Vancouver, BC, Canada
²³Rogel Cancer Center, University of Michigan, Ann Arbor, MI
²⁴Division of Pediatric Blood and Marrow Transplantation, University of Minnesota, Minneapolis, MN
²⁵University of Rochester Medical Center, Rochestser
²⁶Emory University, Winship Cancer Institute, Atlanta, GA
²⁷Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA
²⁸Tulane University, New Orleans

Muhammad Umair Mushtaq^1,2,3, Amir Kasaeian^2,3*, Muhammad Kashif Amin, MD^1,2,3*, Hediyeh Alemi^2,3*, Naghmeh Khavandgar^2,3*, Aqeeb Ur Rehman, MD^2,3*, Sibgha Gull Chaudhary, MD^2,3*, Matthew McGuirk^2,3*, Al-Ola Abdallah, MD^1,2, Anurag K. Singh, MD^1,2,3, Sunil Abhyankar, MD^1,2,3, Mehdi Hamadani, MD^3,4, Joseph P. McGuirk, DO^1,2,3 and Moazzam Shahzad, MD^2,3,5

¹US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS
²Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
³Mikael Rayaan Foundation Global Health Consortium, Kansas City, KS
⁴Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
⁵Department of Oncological Sciences, H. Lee Moffitt Cancer Center, University of South Florida, Tampa, FL

Daniel Dexter, MBBS^1*, Farah O'Boyle^2*, Kirstin Lund, MRCP, BSc^3*, Toni Petterson^4*, Adam Gassas, MD^5*, Leena Karnik, FRCPath, MRCP^6*, Josu de la Fuente, PhD FRCP^7,8,9, Sandrine Bremathas, RN^10* and Kelly Hennessy^11*

¹Department of Haematology, Kings College Hospital, London, ENG, United Kingdom
²Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom
³St Marys Hospital, Imperial College NHS FoundationTrust, London, United Kingdom
⁴St Marys Hospital, Imperial College NHS Foundation Trust London, London, GBR
⁵St Marys Hospital, Imperial College NHS Foundation Trust, London, United Kingdom
⁶St Marys Hospital, Imperial College NHS Foundation Trust, London, GBR
⁷Department of Paediatrics, St Mary’s Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom
⁸Division of Immunology and Inflammation, Imperial College London, London, United Kingdom
⁹Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, United Kingdom
¹⁰IMPERIAL COLLEGE HEALTHCARE NHS TRUST, London, United Kingdom
¹¹St Marys Hospital, Imperial College London, London, United Kingdom

Irwin Walker, MBBS^1,2, Uday Deotare, MBBS, MD, MScHQ^3,4,5*, Mohamed Elemary, MD, MSc, PhD^6*, Mahmoud Elsawy, MD, MSc^7,8*, Genevieve Gallagher, MD^9*, David Kliman, MBBS, FRACP, FRCPA^10*, Tony Panzarella, MSc^11*, Nada Hamad, MBBS, MSc, BSc^12,13,14, Kirk R. Schultz, MD^15,16, Jan Storek, MD, PhD¹⁷ and Kristjan Paulson, MD¹⁸

¹Department of Medicine, McMaster University, Hamilton, ON, Canada
²Juravinski Cancer Centre, Juravinski Hospital and Cancer Centre, Hamilton, ON, Canada
³Princess Margaret Cancer Centre, Toronto, ON, CAN
⁴Schulich School of Medicine & Dentistry, University of Western Ontario, London, ON, Canada
⁵Department of Medicine, Division of Hematology, University of Western Ontario, London, ON, Canada
⁶Provincial Hematology and Blood and Marrow Transplant Program, Saskatchewan Cancer Agency, University of Saskatchewan, Saskatoon, SK, Canada
⁷Dalhousie University, Halifax, NS, Canada
⁸QEII Health Sciences Center, Halifax, NS, Canada
⁹Centre intégré de cancérologie, CHU de Québec - Université Laval, Québec, QC, Canada
¹⁰GenesisCare North Shore, St Leonards, NSW, Australia
¹¹University of Toronto, Toronto, ON, CAN
¹²St Vincent's Hospital, Sydney, NSW, Australia
¹³Haematology Department, The Kinghorn Cancer Centre, St Vincent's Hospital, Darlinghurst, NSW, Australia
¹⁴The University of New South Wales, Kensington, NSW, Australia
¹⁵University of British Columbia, Vancouver, BC, Canada
¹⁶B.C. Children's Hospital, Vancouver, BC, Canada
¹⁷The University of Calgary Department of Medicine, Calgary, Canada
¹⁸Cancercare Manitoba, Winnipeg, MB, Canada

Antonio Bianchessi^1,2*, Irene Defrancesco^1,3*, Virginia Valeria Ferretti^4*, Cristina Picone^5*, Beatrice Ferrari^5*, Caterina Zerbi^1*, Francesco Romano^1,2*, Giulia Losi, MD^1,2*, Erica Consensi^5*, Mara De Amici^6*, Giorgia Testa^7*, Valentina Zoboli^1*, Alessia Taurino^1*, Anna Amelia Colombo^1*, Luca Arcaini^1,2* and Nicola Polverelli¹

¹Unit of Bone Marrow Transplantation - Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
²Department of Molecular Medicine, University of Pavia, Pavia, Italy
³Deparment of Surgical, Clinical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy
⁴Unit of Biostatistics and Clinical Trial Center, Fondazione IRCCS Policlinico S. Matteo, Pavia, Italy
⁵Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
⁶Immuno-Allergology Laboratory of the Clinical Chemistry Unit and Pediatric Clinic, Fondazione IRCCS Policlinico San Matteo, Pavia, ITA
⁷Pediatric Clinic, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

Joseph Rimando, MD¹, Michel Conn^1*, William Blum, MD¹, Jason T Romancik, MD², Colin Vale, MD^3*, Amelia Langston, MD¹, Edmund K. Waller, MD, PhD¹ and Kevin Hall, PharmD^1*

¹Emory University, Winship Cancer Institute, Atlanta, GA
²Department of Hematology and Medical Oncology, Winship Cancer Institute at Emory University, Atlanta, GA
³Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA

Jingbo Yu, MD, PhD^1*, Kristin J. Moore, PhD, MPH^2*, Nicole M. Engel-Nitz, PhD, MS^2*, Mary DuCharme, MLIS^2*, Britnie Thomas, PhD^1*, John Galvin, MD, MPH³ and Valkal Bhatt, PharmD^1*

¹Incyte Corporation, Wilmington, DE
²Optum, Eden Prairie, MN
³Senior Medical Director, Incyte Corporation, Wilmington, DE

Xinghao Yu^1,2*, Yiyin Chen^1,2*, Lei Lei^1,2*, Dandan Lin^1,2*, Ying Shen^1,2*, Chang Hou^1,2*, Jia Chen^1*, Yi Fan^1*, Huimin Lu^3*, Depei Wu, MD, PhD^2,4 and Yang Xu, MD^1,2*

¹National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China
²Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China
³Department of outpatient and emergency, The First Affiliated Hospital of Soochow University, Suzhou, China
⁴The First Affiliated Hospital of Soochow University, Suzhou, China

Sibgha Gull Chaudhary, MD^1,2,3*, Moazzam Shahzad, MD^1,4, Kayla Pfannenstiell^3*, Muhammad Kashif Amin, MD^1,2,3*, Amir Kasaeian^1,3*, Muhammad Fareed Khalid, MD^1,3*, Hediyeh Alemi^1,3*, Naghmeh Khavandgar^1,3*, Iqra Anwar, MBBS^1,3*, Matthew McGuirk^1,3*, Syed Nasir Abbas Bukhari^1,3*, Anurag K. Singh, MD^1,2,3, Mehdi Hamadani, MD^1,5, Joseph P. McGuirk, DO^1,2,3 and Muhammad Umair Mushtaq^1,2,3

¹Mikael Rayaan Foundation Global Health Consortium, Kansas City, KS
²US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS
³Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
⁴Department of Oncological Sciences, H. Lee Moffitt Cancer Center, University of South Florida, Tampa, FL
⁵Department of Medicine, Medical College of Wisconsin, Milwaukee, WI

Alice Bertaina, MD, PhD^1,2,3, Rosa Bacchetta, MD^1,2,3*, Alma-Martina Cepika, MD, PhD^1,2*, David C Shyr, MD^1,2,3, Giulia Barbarito, MS^1,2*, Linda Oppizzi, BS^1,2*, Pauline Chen, MD^1,2*, Gopin Saini, MBBS^1,2*, Jennifer Lee, PhD^1,2*, Karen Kristovich, RN PNP^1,3*, Rajni Agarwal, MD^2,4,5*, Orly Klein, MD^1,2,3, Kathryn Melsop, MS^2,6*, Keri Tate, PhD^2,6*, Matthew Porteus, MD, PhD^1,2,3 and Maria Grazia Roncarolo, MD^1,2,3

¹Department of Pediatrics/ Division of Hematology, Oncology, Stem Cell Transplantation, and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA
²Center for Definitive and Curative Medicine, Stanford University School of Medicine, Stanford, CA
³Lucile Packard Children’s Hospital, Palo Alto, CA
⁴Department of Pediatrics, Division of Hematology, Oncology, Stem Cell Transplantation and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA
⁵Lucile Packard Children’s Hospital, Palo Alto
⁶Laboratory for Cell and Gene Medicine, Stanford University School of Medicine, Palo Alto, CA

Rory McFarland, MD Candidate^1*, Rida Hasan, MD¹ and Sandhya R. Panch, MD^2,3

¹University of Washington, Seattle, WA
²Fred Hutchinson Cancer Center, Seattle, WA
³Fred Hutchinson Cancer Center, Seattle

Elisabeth Dovern, MD^1*, Tim R. Mocking^2,3*, Mette D. Hazenberg, MD, PhD^4,5*, Arjan A. van de Loosdrecht, MD, PhD^2,6*, Simon Tol^7*, Erik Mul^8*, Boukje M. Beuger^7*, Robin van Bruggen^7*, Myrddin Verheij, PhD^3,9*, Carlijn Voermans, PhD^3,9*, Costa Bachas, PhD^2,3*, Bart J. Biemond¹ and Erfan Nur, MD, PhD^1,10

¹Department of Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, Netherlands
²Imaging and Biomarkers, Cancer Center Amsterdam, Amsterdam, Netherlands
³Department of Hematology, Amsterdam UMC location Vrije Universiteit, Amsterdam, Netherlands
⁴Department of Experimental Immunology, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands
⁵Sanquin Research, Amsterdam, Netherlands
⁶Department of Hematology, Amsterdam University Medical Center, Free University, Amsterdam, Netherlands
⁷Department of Molecular Hematology, Sanquin Research and Landsteiner Laboratory, Amsterdam, Netherlands
⁸Department of Research Facilities, Sanquin Research and Landsteiner Laboratory, Amsterdam, Netherlands
⁹Department of Hematopoiesis, Sanquin Research and Landsteiner Laboratory, Amsterdam, Netherlands
¹⁰Department of Blood Cell Research, Sanquin Research and Landsteiner Laboratory, Amsterdam, Netherlands

Scott R. Solomon, MD¹, Melissa Sanacore, PharmD^1*, Lizamarie Bachier Rodriguez, MD¹, Latasha McCoy^1*, Caitlin Guzowski, MBA^1*, Katelin C Jackson^1*, Xu Zhang, PhD^2*, H. Kent Holland, MD^1*, Lawrence E Morris, MD¹, Melhem M. Solh, MD¹ and Asad Bashey, MD, PhD¹

¹Blood and Marrow Transplant Program, Northside Hospital Cancer Institute, Atlanta, GA
²Center for Clinical and Transitional Sciences,, University of Texas, Houston, TX

Victor Ling Wei Teik^1*, Yeh Ching Linn^2*, Huirong Han^1*, Michelle Poon, MBBS, MRCP^1*, Lip Kun Tan^1*, Joanne Shu Xian Lee^1*, Yang Liang Boo, MD, MRCP^1*, Ian Wu, MBBS, MRCP, MD^1*, Jean Rachel Catapia, MD^1*, Aloysius Yew Leng Ho², William Ying Khee Hwang², Yeow Tee Goh, MD², Francesca Lim, MBBS^2*, Hein Than, MD, FRCPath, MRCP², Lawrence Cheng Kiat Ng, MD^2*, Jeffrey Kim Siang Quek^2*, Tertius Tansloan Tuy, MD, MRCP(UK)^2*, Balamurugan Vellayappan^3*, Zi Yi Lim, MBBS, FRCP, FRCPath^4*, Colin Phipps Diong, MD^5*, Yvonne Loh^6*, Kheng Wei Yeoh^7*, Brian Ho^7*, Wen Shen Looi^7*, Yin Jie Koh^1*, Teck Guan Soh^1*, Kee Khiang Heng^8*, Gina Gan^8*, Wing Leung, PhD, MD⁹ and Liang Piu Koh^1*

¹Department of Haematology-Oncology, National University Cancer Institute, Singapore, Singapore
²Department of Haematology, Singapore General Hospital, Singapore, Singapore
³Department of Radiation Oncology, National University Cancer Institute, Singapore, Singapore
⁴Centre for Clinical Haematology, Mount Elizabeth Novena Hospital, Singapore, Singapore
⁵Parkway Cancer Centre, Mount Elizabeth Hospital, Singapore, Singapore
⁶Curie Oncology, Singapore, Singapore
⁷Division of Radiation Oncology, National Cancer Centre Singapore, Singapore, Singapore
⁸Singapore General Hospital, Singapore, Singapore
⁹KK Women’s and Children’s Hospital, Duke-NUS, Singapore, Singapore

Udit Nangia, MD¹, Leland Metheny, MD² and Neeraj Mahajan, MD^3*

¹University Hospitals - Parma Medical Center, Vernon Hills, IL
²Department of Hematology and Stem Cell Transplant, University Hospitals Seidman Cancer Center, Cleveland, OH
³University Hospitals - Parma Medical Center, Parma, OH

Maria Carmen Martinez Munoz, MD, PhD^1*, Leyre Bento De Miguel^2*, Maria Queralt Salas^3*, Juan Montoro^4*, Jaime Sanz^5*, Lucia Lopez Corral, MD^6*, Estefanía Pérez López, MD^6*, Maria Jesús Pascual, MD^7*, Irene García-Cadenas, MD^8*, Maria Suarez-Lledo, MD, PhD^9,10*, Arancha Bermúdez^11*, Felipe Peña, MD^12*, Carlos Carretero^13*, María-José Jiménez Lorenzo^14*, Pedro Antonio González^15*, Antonia Sampol Mayol^16*, Inmaculada Heras, MD^17*, Teresa Zudaire^18*, Pascual Balsalobre^19*, Silvia Filaferro^19*, Angel Cedillo^20*, Carlos Solano, MD, PhD^21,22 and Manuel Jurado Chacón^23*

¹Hematopoietic Cell Transplant Unit, Hospital Clinic of Barcelona, ICAMS, Barcelona, Spain
²Hematology Department, Son Espases University Hospital, IdISBa, Palma, Spain
³Hematopoietic Cell Transplantation Unit, Hospital Clínic de Barcelona, ICAMS, Barcelona, Spain
⁴Hematology Department, Hospital La Fe, Valencia, Spain
⁵Hematology Department, Hospital Universitari i Politècnic La Fe, Departament de Medicina Universitat de Valencia, CIBERONC, Instituto Carlos III, Spain, VALENCIA, Spain
⁶Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca (IBSAL), Centro de Investigación del Cancer (IBMCC-USAL, CSIC), Salamanca, Spain
⁷Hematology Department, Hospital Regional Universitario de Málaga, Málaga, Spain
⁸Hematology Departmen, Hospital de Sant Pau, Barcelona, Spain
⁹Hematopoietic Transplantation Unit, Hematology Department, Clinical Institute of Hematology and Oncology (ICMHO), Spain, Hospital Clínic de Barcelona, Barcelona, Spain
¹⁰Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Barcelona, Spain
¹¹Hospital Marques de Valdecilla (IDIVAL), Santander, Spain
¹²Clinical Hematology Department, Institut Català d’Oncologia-Hospitalet, IDIBELL, Barcelona, Spain
¹³Hematology Department, Hospital Universitario Masqués de Valdecilla, Santander, Spain
¹⁴Hematology Department, Institut Català d’Oncologia de Badalona, Hospital Universitari Germans Trias i Pujol. Institut d’Investigació contra la Leucèmia Josep Carreras. Universitat Autònoma de Barcelona, Badalona, Spain
¹⁵Hematology Department, Hospital Universitario Virgen de las Nieves, Granada, Spain
¹⁶Hematology Department, Hospital Universitario Son Espases, Palma de Mallorca, Spain
¹⁷Hematology Division, Hospital Morales Meseguer, Murcia, Spain
¹⁸Hematology Department, Complejo Hospitalario de Navarra, Pamplona, ESP
¹⁹Grupo Español de Trasplante de Progenitores Hematopoyéticos y Terapia Celular (GETH-TC) Data Office, Madrid, Spain
²⁰GETH Data Office, Madrid, Spain
²¹University of Valencia, Valencia, Spain
²²Hematology Department, Hematology Department, Hospital Clínico Universitario-INCLIVA, Valencia, Spain
²³Hospital Univ. Virgen de las Nieves, Granada, Spain

Rahul Ramaswamy, MD^1*, Laith Fakhoury, BS^1*, Peter Zhao, MD^1*, Ningying Wu, MD, PhD^2*, Feng Gao^3*, Geoffrey L. Uy, MD⁴, John F. DiPersio, MD, PhD⁵ and Zachary D. Crees, MD⁵

¹Washington University School of Medicine, St. Louis, MO
²Public Health Sciences Division, Washington University School of Medicine, St Louis, MO
³Department of Surgery, Division of Public Health Sciences, Washington University School of Medicine, Saint Louis, MO
⁴Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO
⁵Division of Oncology, Washington University School of Medicine, Saint Louis, MO

Yaqun Hong^1,2*, Min Xu^1,2*, Yuanzhong Chen^2*, Nainong Li, MD, PhD^1,3 and Xiaofan Li, MD, PhD^2,4

¹Fujian Medical University, Fuzhou, China
²Fujian Medical University Union Hospital, Fuzhou, China
³Department of Hematology, Fujian Institute of Hematology, Fujian Provincial Key Laboratory on Hematology, Fujian Medical University Union Hospital, Fuzhou, China
⁴Union Clinical Medical Colleges, Fujian Medical University, Fuzhou, China

Tamer Othman, MD¹, Dongyun Yang, PhD^2*, Sally Mokhtari, PhD³, Ibrahim Aldoss, MD⁴, Geoffrey Shouse, PhD, DO⁵, Shukaib Arslan, MD^6*, Leonardo Farol^7*, Leslie L. Popplewell, MD, MPH⁸, Ahmed Aribi, MD^9*, Alex F. Herrera, MD¹⁰, Lihua E. Budde, MD, PhD¹¹, Joshua Mansour, MD^6*, Matthew Mei, MD⁵, Karamjeet S Sandhu, MD⁴, Tanya Siddiqi, MD, MBBS^12*, Jasmine Zain, MD¹⁰, Vaibhav Agrawal, M.D.⁴, Idoroenyi Amanam, MD⁶, Vinod Pullarkat, MD¹³, Tycel J. Phillips, MD¹⁴, Ryotaro Nakamura, MD⁶, Stephen J. Forman, MD, FACP¹⁵ and MHD Monzr M. Al Malki, MD¹⁰

¹Hematology/HCT, City of Hope, San Lorenzo, CA
²Computational and Quantitative Medicine, City of Hope National Medical Center, Duarte, CA
³Clinical and Translational Project Development, City of Hope National Medical Center, Duarte, CA
⁴Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
⁵City of Hope Cancer Center, Duarte, CA
⁶Hematology and HCT, City of Hope National Medical Center, Duarte, CA
⁷City of Hope, Daurte, CA
⁸City of Hope Cancer Treatment Center, Atlanta, GA
⁹Hematology/HCT, City of Hope National Medical Center, Duarte, CA
¹⁰City of Hope, Duarte, CA
¹¹Department of Hematology and HCT, City of Hope, Duarte, CA
¹²City of Hope National Medical Center, Duarte, CA
¹³City of Hope, La Canada, CA
¹⁴City of Hope, Pasadena, CA
¹⁵Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope National Medical Center, Duarte, CA

Yin Liu^*, Ye Zhao^*, Xiaofei Qi^*, Qiao Cheng^*, Jia Chen^*, Xiao Ma^*, Shengli Xue^*, Ying Wang^*, Xiaowen Tang^*, Huiying Qiu^*, Yang Xu, MD^* and Depei Wu

National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China

Marjia Afrin, Ph.D.^1*, Sahar Nasr^1*, Cristabelle De Souza^2*, Brooke Howitt, MD, PhD^3*, Antonia Maria Mueller, MD⁴, Sally Arai, MD⁵, Judith Shizuru^1* and Gerlinde Wernig, MD^6*

¹Stanford University, Stanford, CA
²Stanford, Stanford, CA
³Department of Pathology, Stanford University, Stanford, CA
⁴General Hospital Vienna, Vienna, Austria
⁵Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, CA
⁶Stanford Hospital & Clinics, Stanford, CA

Li Nannan, MD^1*, Yue Lu^2*, Deyan Liu^2*, Min Xiong^3*, Yanli Zhao^2,3*, Ruijuan Sun^3,4*, Zhijie Wei^2,3*, Xingyu Cao^2,3*, Jiarui Zhou^2,3*, Jianping Zhang^2,3* and Peihua Lu, MD^2,3,5

¹Hospital, Yanjiao Economic and Technological Devel, AL, CHN
²Hebei Yanda Lu Daopei Hospital, Langfang, China
³Beijing Lu Daopei Hospital, Beijing, China
⁴Hebei Yanda Lu Daopei Hospital, Beijing, China
⁵Beijing Lu Daopei Institute of Hematology, Beijing, China